共 199 条
[1]
Condorelli RA(2018)Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index J Endocrinol Invest 41 383-388
[2]
Calogero AE(2016)Polycystic ovary syndrome Nat Rev Dis Primers 2 16057-3082
[3]
Di Mauro M(2016)Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review Fertil Res Pract 2 14-1369
[4]
Mongioi’ LM(1998)Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: a prospective study J Clin Endocrinol Metab 83 3078-60
[5]
Cannarella R(2002)Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations Am J Obstet Gynecol 187 1362-488
[6]
Rosta G(2008)The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome Clin Endocrinol (Oxf) 69 52-379
[7]
Azziz R(2009)The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report Fertil Steril 91 456-6
[8]
Carmina E(2018)Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome Hum Reprod 110 364-25
[9]
Chen Z(2004)Diagnosis of Polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines Minerva Ginecol 56 1-1079
[10]
Dunaif A(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 19-231